| __timestamp | Sarepta Therapeutics, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 94231000 | 382096000000 |
| Thursday, January 1, 2015 | 146394000 | 345927000000 |
| Friday, January 1, 2016 | 188272000 | 312303000000 |
| Sunday, January 1, 2017 | 166707000 | 325441000000 |
| Monday, January 1, 2018 | 401843000 | 368298000000 |
| Tuesday, January 1, 2019 | 560909000 | 492381000000 |
| Wednesday, January 1, 2020 | 722343000 | 455833000000 |
| Friday, January 1, 2021 | 771182000 | 526087000000 |
| Saturday, January 1, 2022 | 877090000 | 633325000000 |
| Sunday, January 1, 2023 | 877387000 | 729924000000 |
| Monday, January 1, 2024 | 729924000000 |
Cracking the code
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. This chart compares the R&D expenses of Takeda Pharmaceutical Company Limited and Sarepta Therapeutics, Inc. from 2014 to 2023. Over this period, Takeda's R&D investment has consistently dwarfed that of Sarepta, with Takeda's spending peaking at approximately 730 billion yen in 2023, a staggering 83% increase from 2014. In contrast, Sarepta's R&D expenses grew by nearly 830% over the same period, reaching around 877 million dollars in 2023. This stark difference highlights Takeda's robust financial capacity and long-term strategic focus, while Sarepta's rapid growth underscores its aggressive pursuit of innovation in niche markets. Notably, data for 2024 is incomplete, reflecting the dynamic nature of financial reporting in this sector.
Comparing Innovation Spending: Sanofi and Sarepta Therapeutics, Inc.
Analyzing R&D Budgets: Zoetis Inc. vs Takeda Pharmaceutical Company Limited
R&D Insights: How Zoetis Inc. and Sarepta Therapeutics, Inc. Allocate Funds
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs United Therapeutics Corporation
R&D Insights: How Takeda Pharmaceutical Company Limited and Exelixis, Inc. Allocate Funds
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs Iovance Biotherapeutics, Inc.
Takeda Pharmaceutical Company Limited vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Takeda Pharmaceutical Company Limited or Taro Pharmaceutical Industries Ltd.: Who Invests More in Innovation?
Research and Development Investment: Takeda Pharmaceutical Company Limited vs BioCryst Pharmaceuticals, Inc.
R&D Spending Showdown: Sarepta Therapeutics, Inc. vs Axsome Therapeutics, Inc.
Sarepta Therapeutics, Inc. vs Ultragenyx Pharmaceutical Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs CymaBay Therapeutics, Inc.